生物功能化杂化磁性金纳米颗粒作为光热消融结直肠肝转移瘤的催化剂
研究在大鼠结直肠肝转移模型中,比较抗MG1偶联杂化磁性金纳米颗粒、单纯纳米颗粒与对照组的MRI弛豫测量和光热消融效果;偶联效率为22 μg/mg(55%),靶向组肿瘤坏死百分比38%±29高于单纯纳米颗粒组14%±17和对照组7%±8(P = .043),作者认为靶向纳米颗粒可作为光热消融催化剂扩大消融范围。
要点
- 抗MG1偶联纳米颗粒组肿瘤坏死百分比38%±29,高于单纯纳米颗粒组14%±17和对照组7%±8(P = .043)。
- 抗MG1纳米颗粒组与单纯纳米颗粒组T2*测量值差异有统计学意义(P = .034)。
- 光热消融后抗MG1组平均温度50.2°C±7.8,单纯纳米颗粒组51°C±4.4,对照组39.5°C±2.0。
核心结论
- 靶向单克隆抗体偶联的杂化磁性金纳米颗粒可通过扩大消融范围作为结直肠肝转移瘤光热消融的催化剂。
研究设计与样本
- 动物实验研究,19只Wistar大鼠肝内植入5×10^6个大鼠结直肠肝转移细胞系细胞,分为抗MG1偶联纳米颗粒组(n=6)、单纯纳米颗粒组(n=6)和细胞对照组(n=7),行体素级R2和R2* MRI测量,以近红外808 nm二极管激光0.56 W/cm^2照射3分钟行光热消融,苏木精-伊红染色评估肿瘤坏死,电感耦合等离子体质谱分析生物分布。
诊断标准与关键数值
- 偶联效率为22 μg/mg(55%)。
- 输注前与输注后24小时T2测量值差异有统计学意义(重复测量方差分析,P = .025),T2*测量值差异有统计学意义(P < .001)。
- 抗MG1纳米颗粒组与单纯纳米颗粒组之间T2*测量值差异有统计学意义(P = .034)。
- 光热消融后平均温度±标准差:抗MG1偶联纳米颗粒组50.2°C±7.8,单纯纳米颗粒组51°C±4.4,对照组39.5°C±2.0。
- 肿瘤坏死平均百分比:抗MG1偶联纳米颗粒组38%±29,单纯纳米颗粒组14%±17,对照组7%±8(P = .043)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To demonstrate that anti-MG1 conjugated hybrid magnetic gold nanoparticles (HNPs) act as a catalyst during photothermal ablation (PTA) of colorectal liver metastases, and thus increase ablation zones. Materials and Methods All experiments were performed with approval of the institutional animal care and use committee. Therapeutic and diagnostic multifunctional HNPs conjugated with anti-MG1 monoclonal antibodies were synthesized, and the coupling efficiency was determined. Livers of 19 Wistar rats were implanted with 5 × 106 rat colorectal liver metastasis cell line cells. The rats were divided into three groups according to injection: anti-MG1-coupled HNPs (n = 6), HNPs only (n = 6), and cells only (control group, n = 7). Voxel-wise R2 and R2* magnetic resonance (MR) imaging measurements were obtained before, immediately after, and 24 hours after injection. PTA was then performed with a fiber-coupled near-infrared (808 nm) diode laser with laser power of 0.56 W/cm2 for 3 minutes, while temperature changes were measured. Tumors were assessed for necrosis with hematoxylin-eosin staining. Organs were analyzed with inductively coupled plasma mass spectrometry to assess biodistribution. Therapeutic efficacy and tumor necrosis area were compared by using a one-way analysis of variance with post hoc analysis for statistically significant differences. Results The coupling efficiency was 22 μg/mg (55%). Significant differences were found between preinfusion and 24-hour postinfusion measurements of both T2 (repeated measures analysis of variance, P = .025) and T2* (P < .001). Significant differences also existed for T2* measurements between the anti-MG1 HNP and HNP-only groups (P = .034). Mean temperature ± standard deviation with PTA in the anti-MG1-coated HNP, HNP, and control groups was 50.2°C ± 7.8, 51°C ± 4.4, and 39.5°C ± 2.0, respectively. Inductively coupled plasma mass spectrometry revealed significant tumor targeting and splenic sequestration. Mean percentages of tumor necrosis in the anti-MG1-coated HNP, HNP, and control groups were 38% ± 29, 14% ± 17, and 7% ± 8, respectively (P = .043). Conclusion Targeted monoclonal antibody-conjugated HNPs can serve as a catalyst for photothermal ablation of colorectal liver metastases by increasing ablation zones. © RSNA, 2017.
引用
- White SB, Kim DH, Guo Y, et al. Biofunctionalized Hybrid Magnetic Gold Nanoparticles as Catalysts for Photothermal Ablation of Colorectal Liver Metastases. Radiology. 2017. PMID: 28707960. doi:10.1148/radiol.2017161497
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。